ANDA 86268, held by Lederle. Imipramine Hydrochloride.
As of Nov 15, 2026, ANDA 86268 (Imipramine Hydrochloride), held by Lederle, was not approved, with 1 approved supplement and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Imipramine Hydrochloride50MG ยท tablet;oral | Imipramine Hydrochloride | Discontinued |
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 5, 1982 | Supplement 2Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
